Save the date - May 26, 2023 from 9 to 4:30 pm. EST |
|---|
Opioid Use in Primary Care Virtual annual conferenceDesigned for anyone involved in the care and support of people who use opioids, this one-day event will provide the opportunity to learn about and discuss topics related to opioid use practices, policies, treatments and harm reduction. The conference is accredited
Registration is now open. The conference fee is $100. We offer free or discounted registration for people in financial need. Please contact Robyn Steidman at robyn.steidman@camh.ca. |
Opioid Use in Primary Care Conference 2023
- Opioid Use in Primary Care Conference
The 2023 Conference
Keynote Presentation: Drug Policy in Canada and a Novel Fentanyl Powder Sales Program
Speaker: Christy Sutherland
Dr. Christy Sutherland is a family doctor and diplomat of the American Board of Addiction Medicine who works in Vancouver’s Downtown East Side providing care to Canada’s most vulnerable population.
Dr. Sutherland is the Medical Director of the PHS Community Services Society where she leads a team of physicians and nurses who are embedded in low barrier, harm reduction projects. She received her MD at Dalhousie University and completed her Family Medicine Residency at UBC in 2010. Dr. Sutherland was recognized as the 2018 British Columbia Family Physician of the Year, as well as the recipient of a City of Vancouver Award for Excellence in 2019.
Additional sessions include
- Opioid agonist therapy prescribing in Canada: a case of regionalized knowledge sharing? by Kellia Chiu.
- OAT and pregnancy: An update by Alice Ordean.
- Panel discussion: OAT in the time of fentanyl. Moderator Nikki Bozinoff.
- Panel discussion: Responding to increased drug toxicity. Moderator Tianna Costa.
- Panel discussion: The legal environment. Moderator JF Crepault.
- Bridging the gap between hospital and community: Improving care transitions for patients with opioid use disorder by Narges Beyraghi, Janet Hill and Sofiya Hudani.
- Policy and treatment in corrections by Denise Denning and Louisa Marion-Bellemare.
- Older people’s experience in OAT by Lara Nixon.
- The experience of chronic pain patients. Moderator: Sean Patenaude.
- Utility of urine drug testing in the opioid era by Pamela Kaduri and Cristiana Stefan.
- Opioid overdose response: A simulation by Stephanie Sliekers and Tucker Gordon.
You may also be interested in
Opioid Agonist Therapy: A Prescriber’s Guide to Treatment
Health care providers play a key role in addressing Canada’s opioid use crisis. Opioid Agonist Therapy: A Prescriber’s Guide to Treatment is a comprehensive, practical resource that supports the work of physicians and nurse practitioners who prescribe medication to treat opioid use disorder. It provides the latest guidance for using OAT medications—methadone, buprenorphine, slow-release oral morphine and injectable diacetylmorphine and hydromorphone—to meet the varying needs of people with opioid use disorder. Learn more about the book.
Canadian Opioid Use Disorder Guideline
Canada is in the midst of an opioid crisis, making it important to disseminate standardized approaches and evidence-based recommendations for managing opioid use disorder. Opioid Agonist Therapy: A Synthesis of Canadian Guidelines for Treating Opioid Use Disorder is a national clinical guideline that harmonizes existing guidelines, evidence-based practices and expert opinions into one document, with the aim of providing consistent and high-quality care to people with opioid use disorder.